Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas A Nunez

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1164Boney Joseph, Nicolas A Nunez, Simon Kung, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary ReportBoney Joseph, Nicolas A Nunez, Simon Kung, et al.
Brain Sciences|January 21, 2023
Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort StudyBoney Joseph, Nicolas A Nunez, Vanessa Pazdernik, et al.
Journal of Affective Disorders|July 5, 2022
The genetics of bipolar disorder with obesity and type 2 diabetesAlessandro Miola, Eleanna De Filippis, Marin Veldic, et al.
Journal of Psychiatric Research|June 8, 2023
Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory studyFrancisco Romo-Nava, Thomas Blom, Alfredo B Cuellar-Barboza, et al.
Journal of Affective Disorders|November 5, 2025
Neural signatures of bipolar disorder subtypes: A comprehensive systematic review of neuroimaging studiesAlessandro Miola, Margherita Salvucci, Nicola Meda, et al.
Bipolar Disorders|February 6, 2021
Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort studyMehak Pahwa, Boney Joseph, Nicolas A Nunez, et al.
International Journal of Bipolar Disorders|July 8, 2020
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selectionAlfredo B Cuéllar-Barboza, Susan L McElroy, Marin Veldic, et al.
Molecular Psychiatry|December 13, 2022
Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent maniaManuel Gardea-Resendez, Brandon J Coombes, Marin Veldic, et al.
Journal of Affective Disorders|August 31, 2021
Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidityFrancisco Romo-Nava, Thomas Blom, Alfredo B Cuellar-Barboza, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1164Boney Joseph, Nicolas A Nunez, Simon Kung, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary ReportBoney Joseph, Nicolas A Nunez, Simon Kung, et al.
Brain Sciences|January 21, 2023
Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort StudyBoney Joseph, Nicolas A Nunez, Vanessa Pazdernik, et al.
Journal of Affective Disorders|July 5, 2022
The genetics of bipolar disorder with obesity and type 2 diabetesAlessandro Miola, Eleanna De Filippis, Marin Veldic, et al.
Journal of Psychiatric Research|June 8, 2023
Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory studyFrancisco Romo-Nava, Thomas Blom, Alfredo B Cuellar-Barboza, et al.
Journal of Affective Disorders|November 5, 2025
Neural signatures of bipolar disorder subtypes: A comprehensive systematic review of neuroimaging studiesAlessandro Miola, Margherita Salvucci, Nicola Meda, et al.
Bipolar Disorders|February 6, 2021
Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort studyMehak Pahwa, Boney Joseph, Nicolas A Nunez, et al.
International Journal of Bipolar Disorders|July 8, 2020
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selectionAlfredo B Cuéllar-Barboza, Susan L McElroy, Marin Veldic, et al.
Molecular Psychiatry|December 13, 2022
Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent maniaManuel Gardea-Resendez, Brandon J Coombes, Marin Veldic, et al.
Journal of Affective Disorders|August 31, 2021
Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidityFrancisco Romo-Nava, Thomas Blom, Alfredo B Cuellar-Barboza, et al.
Pageof 3